Van der Poll T, Lowry S F
Department of Surgery, Cornell University Medical College, New York, New York 10021, USA.
Am J Physiol. 1997 Dec;273(6):R1885-90. doi: 10.1152/ajpregu.1997.273.6.R1885.
Epinephrine has been found to inhibit the production of the proinflammatory cytokine tumor necrosis factor (TNF)-alpha and to enhance the production of anti-inflammatory cytokine interleukin (IL)-10. To determine the effect of epinephrine on IL-1 beta production, the following experiments were performed: 1) blood obtained from subjects at 4-21 h after the start of a continuous infusion of epinephrine (30 ng.kg-1.min-1) produced less IL-1 beta after ex vivo stimulation with lipopolysaccharide (LPS), compared with blood drawn from subjects infused with saline; 2) in whole blood in vitro, epinephrine caused a dose-dependent decrease in LPS-induced IL-1 beta production, which was likely mediated via adrenergic receptors; and 3) inhibition of TNF and enhancement of IL-10 both contributed to epinephrine-induced inhibition of IL-1 beta production. Epinephrine, either endogenously produced or administered as a component of sepsis treatment, may attenuate excessive activity of proinflammatory cytokines early in the course of systemic infection.
已发现肾上腺素可抑制促炎细胞因子肿瘤坏死因子(TNF)-α的产生,并增强抗炎细胞因子白细胞介素(IL)-10的产生。为确定肾上腺素对IL-1β产生的影响,进行了以下实验:1)在持续输注肾上腺素(30 ng·kg-1·min-1)开始后4-21小时从受试者采集的血液,经脂多糖(LPS)体外刺激后产生的IL-1β比从输注生理盐水的受试者采集的血液少;2)在全血体外实验中,肾上腺素导致LPS诱导的IL-1β产生呈剂量依赖性减少,这可能是通过肾上腺素能受体介导的;3)TNF的抑制和IL-10的增强均有助于肾上腺素诱导的IL-1β产生的抑制。内源性产生的或作为脓毒症治疗成分给予的肾上腺素,可能在全身感染过程早期减弱促炎细胞因子的过度活性。